Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy

Hayama S.; Nakamura R.; Sangai T.; Nagashima T.; Ohtsuka M.; Yamamoto N.

首页> 外文期刊>The Breast : >Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy

【24h】

Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy

机译：进行Neoadjuvant内分泌治疗的ER阳性乳腺癌患者的生物标志物改变

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Breast :》 |2017年第2017期|共1页
作者
Hayama S.; Nakamura R.; Sangai T.; Nagashima T.; Ohtsuka M.; Yamamoto N.;
展开▼
作者单位

Chiba Univ Grad Sch Med Chiba Japan;

Chiba Canc Ctr Chiba Japan;

Chiba Univ Grad Sch Med Chiba Japan;

Chiba Univ Grad Sch Med Chiba Japan;

Chiba Univ Grad Sch Med Chiba Japan;

Chiba Canc Ctr Chiba Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类胸部外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy [J] . Hayama S., Nakamura R., Sangai T., The Breast : . 2017,第期

机译：进行Neoadjuvant内分泌治疗的ER阳性乳腺癌患者的生物标志物改变
2. Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database [J] . LeVasseur Nathalie, Willemsma Kaylie-Anne, Li Huaqi, Clinical breast cancer . 2019,第6期

机译：Neoadjuvant内分泌治疗与Neoadjuvant化疗在ER阳性乳腺癌中的疗效：潜在机构数据库的结果
3. Expression levels of some genes associated with tumor shrinkage by neoadjuvant endocrine therapy were paradoxically related with poor prognosis in patients with ER-positive/HER2-negative operable breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：通过Neoadjuvant内分泌治疗与肿瘤收缩相关的一些基因的表达水平与ER阳性/ HER2-负操作乳腺癌患者的预后矛盾矛盾
4. A Single Tube Screening of Endocrine Therapy Resistance ESR1 Mutations in ER-Positive Breast Cancer [C] . Akihiro Tsuyada, Shunsuke Nakano, Toshimitsu Ichijo, International Molecular Medicine Tri-Conference. . 2016

机译：ER阳性乳腺癌内分泌治疗抗ESR1突变的单管筛选
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer [O] . Li-Tong Yao, Mo-Zhi Wang, Meng-Shen Wang, 2019

机译：新辅助内分泌治疗：ER阳性乳腺癌的潜在策略
7. Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer [O] . Ho Hyun Ryu, Sei Hyun Ahn, Seon Ok Kim, 2021

机译：Er-阳性，HER2阴性乳腺癌中新辅助内分泌和化疗后代谢变化的比较

Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy

著录项

相似文献

相关主题

期刊订阅